Hosted on MSN1mon
Benchmark retains Omnicell stock Buy rating, $62 price target
and other product initiatives such as OmniSphere and IV compounding robots. These factors, along with the improving financial condition of Omnicell's hospital client base, are said to position the ...
Hosted on MSN27d
Omnicell Gains 41.6% in a Year: What's Driving the Stock?
Omnicell, Inc. OMCL has witnessed strong momentum in the past year. Shares of the company have risen 41.6% against a 11.3% decline of the industry during the same time frame. The S&P 500 composite ...
Morningstar8d
Omnicell Welcomes Perry A. Genova, PhD, as Chief Technology Officer
Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced that Perry A. Genova, PhD, will join the ...